KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Payables (2016 - 2026)

Staar Surgical (STAA) has disclosed Payables for 17 consecutive years, with $11.6 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Payables fell 30.71% year-over-year to $11.6 million, compared with a TTM value of $11.6 million through Jan 2026, down 30.71%, and an annual FY2026 reading of $11.6 million, down 30.71% over the prior year.
  • Payables was $11.6 million for Q1 2026 at Staar Surgical, up from $9.2 million in the prior quarter.
  • Across five years, Payables topped out at $19.1 million in Q2 2024 and bottomed at $7.6 million in Q3 2022.
  • Average Payables over 5 years is $12.5 million, with a median of $12.0 million recorded in 2022.
  • The sharpest move saw Payables surged 81.94% in 2024, then crashed 37.53% in 2025.
  • Year by year, Payables stood at $11.6 million in 2022, then increased by 17.11% to $13.6 million in 2023, then rose by 23.21% to $16.7 million in 2024, then plummeted by 45.04% to $9.2 million in 2025, then rose by 26.08% to $11.6 million in 2026.
  • Business Quant data shows Payables for STAA at $11.6 million in Q1 2026, $9.2 million in Q3 2025, and $12.3 million in Q2 2025.